Linda Baddour, Chief Financial Officer at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 63,000 shares at $34.04 ($2.1M) on 2007-02-09, disclosed to the SEC on 2007-02-12.
Open-market sale of $2.1M PPDI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.87 | 200 | $7K | 0.3% |
| 2 | $33.88 | 200 | $7K | 0.3% |
| 3 | $33.89 | 400 | $14K | 0.6% |
| 4 | $33.90 | 1,300 | $44K | 2.1% |
| 5 | $33.91 | 1,700 | $58K | 2.7% |
| 6 | $33.92 | 1,200 |
| $41K |
| 1.9% |
| 7 | $33.93 | 3,900 | $132K | 6.2% |
| 8 | $33.94 | 1,300 | $44K | 2.1% |
| 9 | $33.95 | 2,336 | $79K | 3.7% |
| 10 | $33.96 | 2,282 | $77K | 3.6% |
| 11 | $33.97 | 1,296 | $44K | 2.1% |
| 12 | $33.98 | 1,806 | $61K | 2.9% |
| 13 | $33.99 | 2,394 | $81K | 3.8% |
| 14 | $34.00 | 3,180 | $108K | 5.0% |
| 15 | $34.01 | 3,406 | $116K | 5.4% |
| 16 | $34.02 | 3,100 | $105K | 4.9% |
| 17 | $34.03 | 2,900 | $99K | 4.6% |
| 18 | $34.04 | 4,585 | $156K | 7.3% |
| 19 | $34.05 | 2,613 | $89K | 4.2% |
| 20 | $34.06 | 5,100 | $174K | 8.1% |
| 21 | $34.07 | 2,236 | $76K | 3.6% |
| 22 | $34.08 | 2,590 | $88K | 4.1% |
| 23 | $34.09 | 4,248 | $145K | 6.8% |
| 24 | $34.10 | 1,364 | $47K | 2.2% |
| 25 | $34.11 | 2,064 | $70K | 3.3% |
| 26 | $34.12 | 400 | $14K | 0.6% |
| 27 | $34.13 | 1,100 | $38K | 1.8% |
| 28 | $34.14 | 3,800 | $130K | 6.1% |
| Total | $34.02 avg | 63,000 | $2.1M | 100% |
| Filing → |
| WAT | SELL | 2021-05-14 | $787K | — | Filing → |
| PRAH | SELL | 2018-01-18 | $12.1M | — | Filing → |
| PRAH | SELL | 2017-08-16 | $15.0M | — | Filing → |